GFAP and early-onset autosomal dominant Alzheimer disease: Visuospatial dysfunction or elevated plasma GFAP may signal a subgroup of RHI/TES patients with Alzheimer’s disease pathology contributing to their symptoms (i.e., Aβ[ +] RHI/TES).